Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection

Immunity

Volumn 4, Issue 3, 1996, Pages 263-273

  Soong, Lynn ^b   Xu, Jian Chao ^b   Grewal, Iqbal S ^b   Kima, Peter ^b   Sun, Jiaren ^b   Jack Longley Jr , B ^a   Ruddle, Nancy H ^b   McMahon Pratt, Diane ^b   Flavell, Richard A ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; NITRIC OXIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; HOST RESISTANCE; IMMUNIZATION; LEISHMANIA; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029925517     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80434-3     Document Type: Article

References (48)

1. Afonso, L.C.C., and Scott, P. (1993). Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect. Immun. 61, 2952-2959.
2. Afonso, L.C.C., Scharton, T.M., Vieira, L.Q., Wysocka, M., Trinchieri, G., and Scott, P. (1994). The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263, 235-237.
3. Alderson, M.R., Armitage, R.J., Tough, T.W., Strockbine, L., Fanslow, W.C., and Spriggs, M.K. (1993). CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178, 669-674.
4. Arredondo, B., and Perez, H. (1979). Alterations of the immune response associated with chronic experimental leishmaniasis. Infect. Immun. 25, 16-22.
5. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J.P., van Kooten, C., Liu, Y.J., Rousset, F., and Saeland, S. (1994). The CD40 antigen and its ligand. Annu. Rev. Immunol. 12, 881-922.
6. Barrai, A., Petersen, E.A., Sacks, D.L, and Neva, F.A. (1983). Late metastatic leishmaniasis in the mouse: a model for mucocutaneous disease. Am. J. Trop. Med. Hyg. 32, 277-285.
7. Barral-Netto, M., Barrai, A., Brownell, C.E., Skeiky, Y.A., Ellingsworth, L.R., Twardzik, D.R., and Reed, S.G. (1992). Transforming growth factor-β in Leishmanial infection: a parasite escape mechanism. Science 257, 545-548.
8. Barten, D.M., and Ruddle, N.H. (1994). Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. J. Neuroimmunol. 51, 123-133.
9. Berman, J.D. (1988). Chemotherapy for leishmaniasis: biochemical mechamisms, clinical efficacy, and future strategies. Rev. Infect. Dis. 10, 560-586.
10. Calabrese, K.D.S., and da Costa, S.C.G. (1992). Enhancement of Leishmania amazonensis infection in BCG non-responder mice by BCG-antigen specific vaccine. Mem. Inst. Oswaldo Cruz. 87, 49-56.
11. + T lymphocytes. J. Immunol. 152, 1523-1531.
12. Chatelain, R., Varkila, K., and Coffman, R.L. (1992). IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148, 1182-1187.
13. Ding, A., Nathan, C.F., Graycar, J., Derynck, R., Stuehr, D.J., and Srimal, S. (1990). Macrophage deactivation factor and transforming growth factors-β1, β2, and β3 inhibit induction of macrophage nitrogen oxide synthesis by IFNγ. J. Immunol. 145, 940-944.
14. Farrington, M., Grosmaire, L.S., Nonoyama, S., Fischer, S.H., Hollenbaugh, D., Ledbetter, J.A., Noelle, R.J., Aruffo, A., and Ochs, H.D. (1994). CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc. Natl. Acad. Sci. USA 91, 1099-1103.
15. Finkelman, F.D., Snapper, C.M., Mountz, J.D., and Katona, I.M. (1987). Polyclonal activation of the murine immune system by a goat antibody to mouse IgD. IX. Induction of a polyclonal IgE response. J. Immunol. 138, 2826-2830.
16. Green, S.J., Meltzer, M.S., Hibbs, J.B., Jr., and Nacy, C.A. (1990). Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144, 278-283.
17. Grewal, I.S., Xu, J.-C., and Flavell, R.A. (1995). Impairment of antigen specific T cell priming in mice lacking CD40 ligand. Nature 378, 617-620.
18. Hathcock, K.S., Laszlo, G., Pucillo, C., Linsley, P., and Hodes, R.J. (1994). Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 180, 631-640.
19. Heinzel, F.P., Sadick, M.D., Holaday, B.J., Coffman, R.L., and Locksley, R.M. (1989). Reciprocal expression of interferon-γ or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169, 59-72.
20. Heinzel, F.P., Schoenhaut, D.S., Rerko, R.M., Rosser, L.E., and Gately, M.K. (1993). Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177, 1505-1509.
21. Heinzel, F.P., Rerko, R.M., Ling, P., Hakimi, J., and Schoenhaut, D.S. (1994). Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect. Immun. 62, 4244-4249.
22. Hollenbaugh, D., Ochs, H.D., Noelle, R.J., Ledbetter, J.A., and Aruffo, A. (1994). The role of CD40 and its ligand in the regulation of the immune response, Immunol. Rev. 138, 23-37.
23. Howard, J.G., Hale, C., and Liew, F.Y. (1980). Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica. J. Exp. Med. 152, 594-607.
24. Laman, J.D., Claassen, E., and Noelle, R.J. (1994). Immunodeficiency due to a faulty interaction between T cells and B cells. Curr. Opin. Immunol. 6, 636-641.
25. Liew, F.Y., Millott, S., Parkinson, C., Palmer, R.M., and Moncada, S. (1990). Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144, 4794-4797.
26. Locksley, R.M., and Scott, P. (1991). Helper T cell subsets in mouse leishmaniasis: induction, expansion and effector function. Immunol. Today 12, A58-61.
27. Moll, H., Folhe, S., and Rollinghoff, M. (1995). Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response. Eur. J. Immunol. 25, 693-699.
28. Moore, K.J., Labrecque, S., and Matlashewski, G. (1993). Alteration of Leishmania donovani infection levels by selective impairment of macrophage signal transduction. J. Immunol. 150, 4457-4465.
29. Murray, H.W., and Hariprashad, J. (1995). Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181, 387-391.
30. Nelson, B.J., Ralph, P., Green, S.J., and Nacy, C.A. (1991). Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-β1. J. Immunol. 146, 1849-1857.
31. Ochs, H.D., Hollenbaugh, D., and Aruffo, A. (1994). The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiency. Sem. Immunol. 6, 337-341.
32. Pan, A.A., and McMahon-Pratt, D. (1988). Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of antigens associated with stage- and species-specific determinants. J. Immunol. 140, 2406-2414.
33. Preston, P.M. (1979). Serum from infected mice suppresses macrophage-mediated immunity in Mycobacterium lepraemurium infection: a model for impaired macrophage immunity in human leprosy. Trans. R. Soc. Trop. Med. Hyg. 73, 212-215.
34. Prina, E., Jouanne, C., de Souza Lao, S., Szabo, A., Guillet, J.-G., and Antoine, J.-C. (1993). Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes. J. Immunol. 151, 2050-2061.
35. Reiner, S.L., Zheng, S., Corry, D.B., and Locksley, R.M. (1993). Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Meth. 165, 37-46.
36. Ruddle, N.H., Bergman, C.M., McGrath, K.M., Lingenheld, E.G., Grunnet, M.L., Padula, S.J., and Clark, R.B. (1990). An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172, 1193-1200.
37. Shu, U., Kiniwa, M., Wu, C.Y., Maliszewski, C., Vezzio, N., Hakimi, J., Gately, M., and Delespesse, G. (1995). Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25, 1125-1128.
38. Soong, L., Duboise, S.M., Kima, K., and McMahon-Pratt, D. (1995). Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis. Infect. Immun. 63, 3559-3566.
39. Stout, R.D., Suttles, J., Xu, J.-C., Grewal, I.S., and Flavell, R.A. (1996). Impaired T cell-mediated macrophage activation in CD40 ligand deficient mice. J. Immunol. 156, 8-11.
40. Sunderkotter, C., Kunz, M., Steinbrink, K., Meinardus-Hager, G., Goebeler, M., Bildau, H., and Sorg, C. (1993). Resistance of mice to experimental leishmaniasis is associated with more rapid appearance of mature macrophages in vitro and in vivo. J. Immunol. 151, 4891-4901.
41. Taswell, C. (1981). Limiting dilution assays for the determination of immunocompetent cell frequencies. J. Immunol. 126, 1614-1619.
42. Tian, L., Noelle, R.L., and Lawrence, D.A. (1995). Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur. J. Immunol. 25, 306-309.
43. van Essen, D., Kikutani, H., and Gray, D. (1995). CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378, 620-623.
44. Vieira, L.Q., Hondowicz, B.D., Afonso, L.C.C., Wysocka, M., Trinchieri, G., and Scott, P. (1994). Infection with Leishmania major induces interleukin-12 production in vivo, Immunol. Lett. 40, 157-161.
45. + T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur. J. Immunol. 24, 3148-3154.
46. Wei, X.-Q., Charles, I.G., Smith, A., Ure, J., Feng, G.-J., Huang, F.-P., Damo, X., Muller, W., Moncada, S., and Liew, F.Y. (1995). Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375, 408-411.
47. Wu, Y., Xu, J.-C., Shinde, S., Grewal, I.S., Henderson, T., Flavell, R.A., and Liu, Y. (1995). Rapid induction of a novel costimulatory activity on B cells by CD40 ligand. Curr. Biol. 5, 1303-1311.
48. Xu, J., Foy, T.M., Laman, J.D., Elliott, E.A., Dunn, J.J., Waldschmidt, T.J., Elsemore, J., Noelle, R.J., and Flavell, R.A. (1994). Mice deficient for the CD40 ligand. Immunity 1, 423-431.